BFM
AKAO

Boothbay Fund Management’s Achaogen Inc AKAO Stock Holding History

Boothbay Fund Management’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-31,200
Closed -$404K – 969
2018
Q1 		$404K Buy
+31,200
New +$354K 0.05% 382

Other funds holding AKAO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Boothbay Fund Management's AKAO Position: Q2 2018 in Review

Boothbay Fund Management sold out of Achaogen Inc (AKAO) in Q2 2018, closing a stake of 31,200 shares — an estimated $404K sold.

Boothbay Fund Management first reported a position in AKAO in Q1 2018 and held it in 1 quarter. The position peaked at $404K in Q1 2018. 102 funds tracked by Wall St. Rank hold AKAO as of Q2 2018.

  • Boothbay Fund Management reported no remaining Achaogen Inc position as of Q2 2018 after selling out during the quarter.
  • Boothbay Fund Management sold 31,200 Achaogen Inc shares in Q2 2018, an estimated $404K.
  • Boothbay Fund Management first reported a position in Achaogen Inc in Q1 2018 and held it in 1 quarter.
  • Boothbay Fund Management's Achaogen Inc position peaked at $404K in Q1 2018.
  • 102 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2018.

Based on Boothbay Fund Management's 13F filing for Q2 2018, filed 14 Aug 2018.